| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $371.3M | -1.9% |
| Cost of Revenue | $247.6M | +5.9% |
| Gross Profit | $123.8M | -14.4% |
| R&D Expense | $7.3M | +7.2% |
| SG&A Expense | $79.5M | -19.7% |
| Operating Income | -$18.5M | -191.6% |
| Pre-tax Income | -$15.5M | -155.9% |
| Income Tax | $204K | +172.0% |
| Net Income | -$15.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.6M | +18.8% |
| Inventory | $72.5M | -15.0% |
| Current Assets | $202.4M | -5.4% |
| Total Assets | $225.4M | -8.9% |
| Current Liabilities | $50.8M | -15.1% |
| Total Liabilities | $55.7M | -23.7% |
| Stockholders' Equity | $169.7M | -2.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.1M | +881.2% |
| Capital Expenditures | $1.5M | +184.9% |
| Investing Cash Flow | -$1.5M | -184.9% |
| Financing Cash Flow | $535K | -98.7% |
| Free Cash Flow | $13.6M | +1246.3% |
| -156.1% |
| EPS (Basic) | -$0.14 | -133.3% |
| EPS (Diluted) | -$0.14 | -133.3% |